1. Home
  2. OII vs IBRX Comparison

OII vs IBRX Comparison

Compare OII & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OII
  • IBRX
  • Stock Information
  • Founded
  • OII 1964
  • IBRX 2014
  • Country
  • OII United States
  • IBRX United States
  • Employees
  • OII N/A
  • IBRX N/A
  • Industry
  • OII Oilfield Services/Equipment
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OII Energy
  • IBRX Health Care
  • Exchange
  • OII Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • OII 2.8B
  • IBRX 2.4B
  • IPO Year
  • OII N/A
  • IBRX N/A
  • Fundamental
  • Price
  • OII $30.37
  • IBRX $4.73
  • Analyst Decision
  • OII Buy
  • IBRX Buy
  • Analyst Count
  • OII 4
  • IBRX 2
  • Target Price
  • OII $27.00
  • IBRX $17.38
  • AVG Volume (30 Days)
  • OII 734.3K
  • IBRX 4.6M
  • Earning Date
  • OII 10-23-2024
  • IBRX 11-12-2024
  • Dividend Yield
  • OII N/A
  • IBRX N/A
  • EPS Growth
  • OII 76.07
  • IBRX N/A
  • EPS
  • OII 1.32
  • IBRX N/A
  • Revenue
  • OII $2,602,340,000.00
  • IBRX $7,332,000.00
  • Revenue This Year
  • OII $9.75
  • IBRX $2,572.99
  • Revenue Next Year
  • OII $7.25
  • IBRX $747.59
  • P/E Ratio
  • OII $23.03
  • IBRX N/A
  • Revenue Growth
  • OII 12.84
  • IBRX 1218.71
  • 52 Week Low
  • OII $18.67
  • IBRX $3.10
  • 52 Week High
  • OII $30.65
  • IBRX $10.53
  • Technical
  • Relative Strength Index (RSI)
  • OII 65.55
  • IBRX 51.45
  • Support Level
  • OII $29.71
  • IBRX $4.86
  • Resistance Level
  • OII $30.65
  • IBRX $5.22
  • Average True Range (ATR)
  • OII 0.88
  • IBRX 0.34
  • MACD
  • OII 0.16
  • IBRX -0.06
  • Stochastic Oscillator
  • OII 83.50
  • IBRX 54.20

About OII Oceaneering International Inc.

Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

Share on Social Networks: